Talk:Galderma

L'Oréal will pay €3.4 billion (USD$4.63 billion) for the remaining 27.3 million shares.[6]

This doesn't seem to make a whole lot of sense here, since Nestle bought Galderma. The source is not available anymore, unfortunately. Maybe the sentence is about a separate transaction? In this case, it should be deleted from the Galderma-page. - 130.60.152.125 (talk) 13:50, 3 March 2015 (UTC)

Proposal for updates

Hello,

We would like to add two pieces of content (either at the end of the History section, or into the Activities section), following the results of clinical studies, and are seeking the approval of the community.

First piece of content:

In June 2022, Galderma announced positive results in two Phase III trials for liquid botulinum toxin A, showing RelabotulinumtoxinA significantly reduced frown line severity and was well tolerated. This result primes the company to apply for approval in the US and other global markets.

Source: https://aestheticmed.co.uk/site/shownewsdetails/galderma-announces-positive-results-in-two-phase-i

Second piece of content:

In June 2022, Galderma announced positive data from Phase III trial, showing efficacy and safety of nemolizumab in patients with prurigo nodularis. Nemolizumab is a monoclonal antibody that blocks the signaling of IL-31, a neuroimmune cytokine involved in the pathogenesis of prurigo nodularis.

Source: https://clinicaltrials.gov/ct2/show/NCT04501666, https://finance.yahoo.com/news/galderma-announces-positive-data-phase-060000232.html

Many thanks for your feedback and advice,

Galderma21 Galderma21 (talk) 13:00, 20 December 2022 (UTC)

extensive COI editing

Article has been extensively edited by User:Galderma21, it needs a thorough review. In addition, User:Galderma21 appears to be a shared account by their own admission. — Preceding unsigned comment added by 46.140.57.254 (talk) 20:05, 25 April 2024 (UTC)

August 2025 updates

Hello, as agreed in the talk pages I'm going through this talk page before editing anything.

These are the changes I would like to make:

- In the infobox, change "founded in texas in 1961" (this is incorrect and the source does not exist anymore) and replace by "founded as a joint venture between L'Oréal and Nestlé in 1981".

I know company sources are not ideal but we can refer to this page https://www.galderma.com/glance. And this one is already used in the page https://apnews.com/nestle-exchanges-stake-in-loreal-for-galderma-1a7c5cb4ebf743b391659ad9580a6981

- In the activities section, change the name of the section "botulinum toxin" by "Aesthetics" or “Injectable Aesthetics”. Indeed botulinum toxin is not the only category Galderma operates in; we are also active in hyaluronic acid fillers and biostimulators, making the current “botulinum toxin” title incorrect.

This Swiss source (in French) says it for instance - if the explanation above is not sufficient. https://www.allnews.ch/content/points-de-vue/la-beaut%C3%A9-qui-rapporte-des-milliards

I may have further edit proposals later but this is all for now. Many thanks. Kilsanerd04 (talk) 15:30, 13 August 2025 (UTC)